Corporation (NASDAQ:LFVN), a company specializing in nutrigenomics, announced the appointment of Todd Thompson as its new Chief Information and Innovation Officer. The company, which has demonstrated ...

We are thrilled to welcome Todd to the LifeVantage team,” said Steve Fife, President and CEO of LifeVantage. “Todd’s exceptional track record in technology leadership and his forward-thinking approach ...

LifeVantage's new MindBody GLP-1 System is riding the coattails of GLP-1 weight loss drugs. See why I rate LFVN stock as a ...

LifeVantage (NASDAQ:LFVN – Get Free Report) and Checkpoint Therapeutics (NASDAQ:CKPT – Get Free Report) are both small-cap medical companies, but which is the superior investment? We will contrast the ...

Fintel reports that on January 14, 2025, Craig-Hallum initiated coverage of LifeVantage (NasdaqCM:LFVN) with a Buy ...

LifeVantage (LFVN) announced the results of a third-party cell study on the synergistic impact of Protandim Nrf2 Synergizer ...

SALT LAKE CITY, Jan. 08, 2025 (GLOBE NEWSWIRE) -- (Nasdaq: LFVN), a leading health and wellness company with products ...

LifeVantage Corporation hosted its annual Global Kickoff on January 11, 2025, drawing thousands of independent Consultants to celebrate the company’s vision for the year, focusing on momentum ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

SALT LAKE CITY - LifeVantage (NASDAQ:LFVN) Corporation (NASDAQ:LFVN), a company focused on nutrigenomics and wellness products with a market capitalization of $282 million, has announced the ...

SALT LAKE CITY - LifeVantage (NASDAQ:LFVN) Corporation (NASDAQ:LFVN), a company focused on nutrigenomics and wellness products with a market capitalization of $282 million, has announced the global ...

Corporation announces the addition of Todd Thompson as Chief Information and Innovation Officer. Todd brings decades of ...